Median numbers needed to treat. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy5

Median Eminence Lymph Nodes Hematopoietic Stem Cells Sternum Cell Line, Tumor

Diseases56

Recurrence Neoplasm Recurrence, Local Neutropenia Disease Progression Breast Neoplasms Lymphoma, Non-Hodgkin Neoplasm Metastasis Leukopenia Nausea Lung Neoplasms Adenocarcinoma Neoplasms Lymphatic Metastasis Multiple Myeloma Alopecia Colorectal Neoplasms Vomiting Thrombocytopenia Hematologic Neoplasms Acute Disease Brain Neoplasms Graft vs Host Disease Drug-Related Side Effects and Adverse Reactions Hodgkin Disease Carcinoma Liver Neoplasms HIV Infections Stomach Neoplasms Chronic Disease Postoperative Complications Ovarian Neoplasms Lymphoma, Follicular Carcinoma, Non-Small-Cell Lung Diarrhea Fatigue Prostatic Neoplasms Melanoma Median Neuropathy Bone Neoplasms Disease Models, Animal Pancreatic Neoplasms Stroke Pain Carcinoma, Squamous Cell Hematologic Diseases Kidney Neoplasms Radiation Injuries Sarcoma Myocardial Infarction Precursor Cell Lymphoblastic Leukemia-Lymphoma Skin Neoplasms Kidney Failure, Chronic Leukemia, Myeloid, Acute Glioblastoma Carcinoma, Renal Cell Anemia

Chemicals and Drugs51

Granulocyte Colony-Stimulating Factor Cyclophosphamide Antineoplastic Agents Etoposide Paclitaxel Cisplatin Antineoplastic Agents, Phytogenic Deoxycytidine Carboplatin Fluorouracil Antimetabolites, Antineoplastic Antigens, CD34 Camptothecin Doxorubicin Ifosfamide Antineoplastic Agents, Alkylating Organoplatinum Compounds Epirubicin Cytarabine Taxoids Vincristine Antibodies, Monoclonal, Humanized Leucovorin Carmustine Antibodies, Monoclonal Tegafur Melphalan Methotrexate Oxonic Acid Vinblastine Recombinant Proteins Drug Combinations Antibodies, Monoclonal, Murine-Derived Dexamethasone Anti-Bacterial Agents Biological Markers Prednisone Immunosuppressive Agents Anti-HIV Agents Tumor Markers, Biological Dacarbazine Plant Extracts Antiviral Agents Thalidomide Anti-Inflammatory Agents Bleomycin Interferon-alpha Prostate-Specific Antigen Prednisolone Placebos Antineoplastic Agents, Hormonal

Analytical, Diagnostic and Therapeutic Techniques and Equipment111

Treatment Outcome Antineoplastic Combined Chemotherapy Protocols Retrospective Studies Drug Administration Schedule Follow-Up Studies Disease-Free Survival Survival Rate Prospective Studies Survival Analysis Hematopoietic Stem Cell Mobilization Transplantation, Autologous Hematopoietic Stem Cell Transplantation Combined Modality Therapy Salvage Therapy Infusions, Intravenous Leukapheresis Neoplasm Staging Prognosis Lymph Node Excision Remission Induction Blood Component Removal Platelet Transfusion Kaplan-Meier Estimate Cohort Studies Risk Factors Feasibility Studies Treatment Failure Pilot Projects Maximum Tolerated Dose Statistics, Nonparametric Transplantation, Homologous Blood Cell Count Double-Blind Method Administration, Oral Questionnaires Leukocyte Count Transplantation Conditioning Chemotherapy, Adjuvant Platelet Count Severity of Illness Index Bone Marrow Transplantation Multivariate Analysis Length of Stay Cross-Sectional Studies Proportional Hazards Models Drug Therapy, Combination Predictive Value of Tests Risk Assessment Incidence Colectomy Reproducibility of Results Case-Control Studies Hospitalization Chi-Square Distribution Blood Transfusion Cell Count Prevalence Laparoscopy Data Collection Catheter Ablation Confidence Intervals Logistic Models Tomography, X-Ray Computed Radiotherapy Dosage Sensitivity and Specificity Randomized Controlled Trials as Topic Clinical Trials as Topic Reoperation Radiotherapy, Adjuvant Analysis of Variance Patient Selection Palliative Care CD4 Lymphocyte Count Regression Analysis Magnetic Resonance Imaging Drug Evaluation Disease Models, Animal Probability Dose Fractionation Radiosurgery Viral Load Retreatment Longitudinal Studies Reference Values Registries Radiotherapy Actuarial Analysis Brachytherapy Phytotherapy Immunohistochemistry Stents Sternotomy Injections, Intravenous Biopsy Risk Area Under Curve Antiretroviral Therapy, Highly Active Neoadjuvant Therapy Life Tables Blood Vessel Prosthesis Implantation Linear Models Odds Ratio Radiotherapy, Conformal Liver Transplantation Postoperative Care Cross-Over Studies Equipment Design Stem Cell Transplantation Placebos Prosthesis Design Catheterization

Psychiatry and Psychology2

Pain Patient Compliance

Phenomena and Processes22

Time Factors Dose-Response Relationship, Drug Maximum Tolerated Dose Drug Resistance, Neoplasm Blood Cell Count Leukocyte Count Graft Survival Platelet Count Chi-Square Distribution Cell Count Pregnancy Sensitivity and Specificity CD4 Lymphocyte Count Probability Viral Load Pain Risk Area Under Curve Algorithms Odds Ratio Gestational Age Recovery of Function

Disciplines and Occupations2

Immunohistochemistry Outcome Assessment (Health Care)

Anthropology, Education, Sociology and Social Phenomena2

Quality of Life Survival

Humanities1

Quality of Life

Information Science12

Survival Rate Bibliometrics Questionnaires Publishing Incidence Databases, Factual Prevalence Data Collection Registries Life Tables Algorithms Radiotherapy, Conformal

Named Groups1

Infant, Newborn

Health Care60

Treatment Outcome Retrospective Studies Follow-Up Studies Disease-Free Survival Survival Rate Prospective Studies Survival Analysis Kaplan-Meier Estimate Cohort Studies Risk Factors Feasibility Studies Treatment Failure Pilot Projects Statistics, Nonparametric Double-Blind Method Questionnaires Severity of Illness Index Multivariate Analysis Length of Stay Cross-Sectional Studies Proportional Hazards Models Predictive Value of Tests Risk Assessment Incidence Age Factors Reproducibility of Results Case-Control Studies Hospitalization Chi-Square Distribution Prevalence Data Collection Physician's Practice Patterns Confidence Intervals Logistic Models Refusal to Treat Intention to Treat Analysis Sensitivity and Specificity Randomized Controlled Trials as Topic Clinical Trials as Topic Analysis of Variance Patient Selection Palliative Care Regression Analysis Probability Longitudinal Studies Registries Actuarial Analysis Sex Factors Risk Area Under Curve Radiation Injuries Life Tables Linear Models Odds Ratio Postoperative Care Outcome Assessment (Health Care)Cross-Over Studies Patient Compliance Cost-Benefit Analysis Practice Guidelines as Topic

Geographicals7

United States Great Britain England Italy Germany Europe Japan

Anatomy Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care Geographicals

Treatment Outcome Antineoplastic Combined Chemotherapy Protocols Retrospective Studies Drug Administration Schedule Follow-Up Studies Time Factors Disease-Free Survival Survival Rate Prospective Studies Survival Analysis Hematopoietic Stem Cell Mobilization Transplantation, Autologous Hematopoietic Stem Cell Transplantation Combined Modality Therapy Salvage Therapy Granulocyte Colony-Stimulating Factor Recurrence Infusions, Intravenous Cyclophosphamide Leukapheresis Antineoplastic Agents Etoposide Paclitaxel Neoplasm Recurrence, Local Cisplatin Neoplasm Staging Prognosis Neutropenia Lymph Node Excision Remission Induction Blood Component Removal Antineoplastic Agents, Phytogenic Disease Progression Deoxycytidine Carboplatin Breast Neoplasms Fluorouracil Lymphoma, Non-Hodgkin Platelet Transfusion Kaplan-Meier Estimate Antimetabolites, Antineoplastic Cohort Studies Neoplasm Metastasis Risk Factors Feasibility Studies Antigens, CD34 Dose-Response Relationship, Drug Treatment Failure Camptothecin Doxorubicin Pilot Projects Maximum Tolerated Dose Leukopenia Ifosfamide Nausea Antineoplastic Agents, Alkylating Statistics, Nonparametric Organoplatinum Compounds Transplantation, Homologous Lung Neoplasms Epirubicin Adenocarcinoma Drug Resistance, Neoplasm Neoplasms Blood Cell Count Cytarabine Lymphatic Metastasis Taxoids Multiple Myeloma Alopecia Vincristine Bibliometrics Colorectal Neoplasms Double-Blind Method Vomiting Median Eminence Antibodies, Monoclonal, Humanized Administration, Oral Questionnaires Leucovorin Leukocyte Count Transplantation Conditioning Graft Survival Carmustine Antibodies, Monoclonal Thrombocytopenia Chemotherapy, Adjuvant Tegafur Platelet Count Severity of Illness Index Melphalan Hematologic Neoplasms Methotrexate Bone Marrow Transplantation Oxonic Acid Vinblastine Acute Disease Brain Neoplasms Multivariate Analysis Graft vs Host Disease

No FAQ available that match "median numbers needed to treat"